CD9-binding peptide
CD9-binding peptide is a CD9-binding peptide. CD9-binding peptide inhibits the binding of EWI-2 to CD9. CD9-binding peptide exhibits selective anti-migratory and anti-invasive activities against cancer cells. CD9-binding peptide can be used for the study of cancer[1].
Product Specifications
CAS Number
2843551-32-4
UNSPSC
12352209
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
OC([C@H](CC1=CN=CN1)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H](CO)NC([C@@H](N)CCCNC(N)=N)=O)=O)CC2=CN=CN2)=O)=O)=O)=O)=O)=O
Molecular Formula
C45H79N21O10
Molecular Weight
1074.24
References & Citations
[1]Suwatthanarak T, et al. Inhibition of cancer-cell migration by tetraspanin CD9-binding peptide. Chem Commun (Camb) . 2021 May 18;57 (40) :4906-4909.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
